Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells

Abstract

Cell-permeable peptides (CPPs) promote the transduction of nonpermissive cells by recombinant adenovirus (rAd) to improve the therapeutic efficacy of rAd. In this study, branched oligomerization of CPPs significantly enhanced the transduction of human mesenchymal stem cells (MSCs) by rAd in a CPP type-independent manner. In particular, tetrameric CPPs increased transduction efficiency at 3000–5000-fold lower concentrations than did monomeric CPPs. Although branched oligomerization of CPPs also increases cytotoxicity, optimal concentrations of tetrameric CPPs required for maximum transduction are at least 300–1000-fold lower than those causing 50% cytotoxicity. Furthermore, although only 60% of MSCs were maximally transduced at 500 μM of monomeric CPPs, >95% of MSCs were transduced with 0.1 μM of tetrameric CPPs. Tetrameric CPPs also significantly increased the formation and net surface charge of CPP/rAd complexes, as well as the binding of rAd to cell membranes at a greater degree than did monomeric CPPs, followed by rapid internalization into MSCs. In a critical-size calvarial defect model, the inclusion of tetrameric CPPs in ex vivo transduction of rAd expressing bone morphogenetic protein 2 into MSCs promoted highly mineralized bone formation. In addition, MSCs that were transduced with rAd expressing brain-derived neurotrophic factor in the presence of tetrameric CPPs improved functional recovery in a spinal cord injury model. These results demonstrated the potential for tetrameric CPPs to provide an innovative tool for MSC-based gene therapy and for in vitro gene delivery to MSCs.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.

    Article  CAS  Google Scholar 

  2. Deans RJ, Moseley AB . Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875–884.

    Article  CAS  Google Scholar 

  3. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H . Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 2581–2587.

    Article  CAS  Google Scholar 

  4. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846–12851.

    Article  CAS  Google Scholar 

  5. Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD . Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 329–340.

    Article  CAS  Google Scholar 

  6. Nauta AJ, Fibbe WE . Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499–3506.

    Article  CAS  Google Scholar 

  7. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF . Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005; 5: 1571–1584.

    Article  CAS  Google Scholar 

  8. Abdallah BM, Kassem M . Human mesenchymal stem cells: from basic biology to clinical applications. Gene Therapy 2008; 15: 109–116.

    Article  CAS  Google Scholar 

  9. Wilson JM . Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185–1187.

    Article  CAS  Google Scholar 

  10. Volpers C, Kochanek S . Adenoviral vectors for gene transfer and therapy. J Gene Med 2004; 6 (Suppl 1): S164–S171.

    Article  CAS  Google Scholar 

  11. Wang Y, Liu S, Li CY, Yuan F . A novel method for viral gene delivery in solid tumors. Cancer Res 2005; 65: 7541–7545.

    Article  CAS  Google Scholar 

  12. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K et al. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 2003; 7: 354–365.

    Article  CAS  Google Scholar 

  13. Mizuguchi H, Sasaki T, Kawabata K, Sakurai F, Hayakawa T . Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells. Biochem Biophys Res Commun 2005; 332: 1101–1106.

    Article  CAS  Google Scholar 

  14. Knaan-Shanzer S, van de Watering MJ, van der Velde I, Goncalves MA, Valerio D, de Vries AA . Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 2005; 23: 1598–1607.

    Article  Google Scholar 

  15. Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R et al. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003; 9: 357–362.

    Article  CAS  Google Scholar 

  16. Youn JI, Park SH, Jin HT, Lee CG, Seo SH, Song MY et al. Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Ther 2008; 15: 703–712.

    Article  CAS  Google Scholar 

  17. Kawamura KS, Sung M, Bolewska-Pedyczak E, Gariepy J . Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells. Biochemistry 2006; 45: 1116–1127.

    Article  CAS  Google Scholar 

  18. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, Rosenecker J . Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11411–11418.

    Article  CAS  Google Scholar 

  19. Johnson JR, Jiang H, Smith BD . Zinc(II)-coordinated oligotyrosine: a new class of cell penetrating peptide. Bioconjug Chem 2008; 19: 1033–1039.

    Article  CAS  Google Scholar 

  20. Vives E, Brodin P, Lebleu B . A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272: 16010–16017.

    Article  CAS  Google Scholar 

  21. Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006; 12: 574–579.

    Article  CAS  Google Scholar 

  22. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A . Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996; 271: 18188–18193.

    Article  CAS  Google Scholar 

  23. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84-A: 2123–2134.

    Article  Google Scholar 

  24. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF . The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991; 252: 554–558.

    Article  CAS  Google Scholar 

  25. Basso DM, Beattie MS, Bresnahan JC . Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244–256.

    Article  CAS  Google Scholar 

  26. Kuh SU, Cho YE, Yoon DH, Kim KN, Ha Y . Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 2005; 147: 985–992; discussion 992.

    Article  Google Scholar 

  27. Futaki S . Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002; 245: 1–7.

    Article  CAS  Google Scholar 

  28. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836–5840.

    Article  CAS  Google Scholar 

  29. Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K et al. Use of protamine to augment adenovirus-mediated cancer gene therapy. Gene Therapy 1999; 6: 1600–1610.

    Article  CAS  Google Scholar 

  30. Toyoda K, Nakane H, Heistad DD . Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab 2001; 21: 1125–1131.

    Article  CAS  Google Scholar 

  31. Kuhnel F, Schulte B, Wirth T, Woller N, Schafers S, Zender L et al. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 2004; 78: 13743–13754.

    Article  Google Scholar 

  32. Kurachi S, Tashiro K, Sakurai F, Sakurai H, Kawabata K, Yayama K et al. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity. Gene Therapy 2007; 14: 1160–1165.

    Article  CAS  Google Scholar 

  33. Han T, Tang Y, Ugai H, Perry LE, Siegal GP, Contreras JL et al. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy. Virol J 2007; 4: 103.

    Article  Google Scholar 

  34. Ha SJ, Chang J, Song MK, Suh YS, Jin HT, Lee CH et al. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nat Biotechnol 2002; 20: 381–386.

    Article  Google Scholar 

  35. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585–590.

    Article  CAS  Google Scholar 

  36. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003; 21: 513–518.

    Article  CAS  Google Scholar 

  37. Choi JS, Kim HY, Cha JH, Choi JY, Park SI, Jeong CH et al. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem 2007; 55: 821–830.

    Article  CAS  Google Scholar 

  38. Basso DM, Beattie MS, Bresnahan JC . A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1–21.

    Article  CAS  Google Scholar 

  39. Takami T, Oudega M, Bethea JR, Wood PM, Kleitman N, Bunge MB . Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma 2002; 19: 653–666.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Mun-Young Lee in the Catholic University of Korea for advising histological analysis, Yoon-Sun Yang in Medipost Co. for the human UCB-MSC, Sang-Chun Lee and Kwan Seok Lee in POSTECH for devoted animal care, as well as Hong-Hwa Jun in Genexine Co. for the technical assistance. This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST). (No. M10534050001-08N3405-00110) and by a grant from National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0820040) and by a grant from Biod, Korea.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S-S Jeun or Y C Sung.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, SH., Doh, J., Park, S. et al. Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells. Gene Ther 17, 1052–1061 (2010). https://doi.org/10.1038/gt.2010.58

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2010.58

Keywords

This article is cited by

Search

Quick links